RESULTS
Participants
Twenty children with challenge-confirmed peanut allergy, mean age of 8.2
(SD, 3.0) years were enrolled (Table 1). Four children withdrew during
treatment (additional details in supporting information); 16 completed
18-months of treatment and attended the end-of-treatment (T2) and 8-week
post-treatment (T3) DBPCFCs; 14 completed T4 and/or T5 DBPCFC (Figure
1).